Corvus Pharmaceuticals' Short Runway Overshadows Soquelitinib's Promising Trials

Group 1 - Corvus Pharmaceuticals is a biopharmaceutical company focused on developing treatments for autoimmune conditions and cancer [1] - The leading candidate of the company is Soquelitinib, an ITK inhibitor that possesses anti-inflammatory and anti-tumor properties [1]